ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Wyvern Pharma Ltd

Wyvern Pharma Ltd is an active company incorporated on 23 October 2014 with the registered office located in Accrington, Lancashire. Wyvern Pharma Ltd was registered 11 years ago.
Status
Active
Active since incorporation
Company No
09276399
Private limited company
Age
11 years
Incorporated 23 October 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 4 August 2025 (3 months ago)
Next confirmation dated 4 August 2026
Due by 18 August 2026 (9 months remaining)
Last change occurred 1 year 3 months ago
Accounts
Submitted
For period 1 Oct30 Sep 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 30 September 2025
Due by 30 June 2026 (7 months remaining)
Address
Wyvern Pharmacy
81 Abbey Street
Accrington
Lancashire
BB5 1EH
England
Same address for the past 7 years
Telephone
01254 875008
Email
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • Pharmacist • British • Lives in England • Born in Apr 1993
Director • British • Lives in England • Born in Mar 1976
Zgi Capital Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Caducifer Medical Services Limited
Ahmed Altaf Zackaria is a mutual person.
Active
Darmansaz & Aso Limited
Aso Rashed Hussain is a mutual person.
Active
Zgi Capital Ltd
Ahmed Altaf Zackaria is a mutual person.
Active
Clarendon Pharma Limited
Ahmed Altaf Zackaria is a mutual person.
Active
Oddeseay Ltd
Ahmed Altaf Zackaria is a mutual person.
Dissolved
Chapel Allerton Pharma Limited
Ahmed Altaf Zackaria is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Sep 2024
For period 30 Sep30 Sep 2024
Traded for 12 months
Cash in Bank
£30.41K
Decreased by £15K (-33%)
Turnover
Unreported
Same as previous period
Employees
5
Decreased by 1 (-17%)
Total Assets
£131.54K
Decreased by £5.78K (-4%)
Total Liabilities
-£162.91K
Increased by £3.95K (+2%)
Net Assets
-£31.38K
Decreased by £9.73K (+45%)
Debt Ratio (%)
124%
Increased by 8.09% (+7%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 30 Sep 2025
Confirmation Submitted
2 Months Ago on 15 Aug 2025
Full Accounts Submitted
1 Year 1 Month Ago on 23 Sep 2024
Confirmation Submitted
1 Year 3 Months Ago on 4 Aug 2024
Darmansaz & Aso Limited (PSC) Resigned
1 Year 3 Months Ago on 31 Jul 2024
Zgi Capital Limited (PSC) Details Changed
1 Year 3 Months Ago on 31 Jul 2024
Osman Altaf Zackaria Resigned
1 Year 3 Months Ago on 31 Jul 2024
Aso Rashed Hussain Resigned
1 Year 3 Months Ago on 31 Jul 2024
Confirmation Submitted
1 Year 9 Months Ago on 13 Jan 2024
Abridged Accounts Submitted
2 Years 8 Months Ago on 16 Feb 2023
Get Credit Report
Discover Wyvern Pharma Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 30 September 2024
Submitted on 30 Sep 2025
Confirmation statement made on 4 August 2025 with no updates
Submitted on 15 Aug 2025
Cessation of Darmansaz & Aso Limited as a person with significant control on 31 July 2024
Submitted on 19 Nov 2024
Total exemption full accounts made up to 30 September 2023
Submitted on 23 Sep 2024
Termination of appointment of Aso Rashed Hussain as a director on 31 July 2024
Submitted on 4 Aug 2024
Termination of appointment of Osman Altaf Zackaria as a secretary on 31 July 2024
Submitted on 4 Aug 2024
Confirmation statement made on 4 August 2024 with updates
Submitted on 4 Aug 2024
Change of details for Zgi Capital Limited as a person with significant control on 31 July 2024
Submitted on 4 Aug 2024
Confirmation statement made on 5 January 2024 with no updates
Submitted on 13 Jan 2024
Unaudited abridged accounts made up to 30 September 2022
Submitted on 16 Feb 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year